Piper Sandler Maintains Overweight on Exelixis, Raises Price Target to $36
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Joseph Catanzaro has maintained an Overweight rating on Exelixis (NASDAQ:EXEL) and raised the price target from $33 to $36.
October 30, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler has maintained an Overweight rating on Exelixis and increased the price target from $33 to $36, indicating a positive outlook.
The increase in price target from $33 to $36 by Piper Sandler suggests a positive outlook for Exelixis, likely leading to a short-term price increase. The Overweight rating indicates confidence in the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100